326 related articles for article (PubMed ID: 33269103)
1. Pituitary Adenylate Cyclase-Activating Polypeptide: A Promising Neuroprotective Peptide in Stroke.
Fang Y; Ren R; Shi H; Huang L; Lenahan C; Lu Q; Tang L; Huang Y; Tang J; Zhang J; Zhang JH
Aging Dis; 2020 Dec; 11(6):1496-1512. PubMed ID: 33269103
[TBL] [Abstract][Full Text] [Related]
2. Alternative Routes of Administration of the Neuroprotective Pituitary Adenylate Cyclase Activating Polypeptide.
Reglodi D; Atlasz T; Jungling A; Szabo E; Kovari P; Manavalan S; Tamas A
Curr Pharm Des; 2018; 24(33):3892-3904. PubMed ID: 30417775
[TBL] [Abstract][Full Text] [Related]
3. Pituitary Adenylate Cyclase-Activating Polypeptide (PACAP) Is Involved in Adult Mouse Hippocampal Neurogenesis After Stroke.
Matsumoto M; Nakamachi T; Watanabe J; Sugiyama K; Ohtaki H; Murai N; Sasaki S; Xu Z; Hashimoto H; Seki T; Miyazaki A; Shioda S
J Mol Neurosci; 2016 Jun; 59(2):270-9. PubMed ID: 26910758
[TBL] [Abstract][Full Text] [Related]
4. Pituitary adenylate cyclase activating polypeptide: a potential neuroprotective peptide.
Somogyvári-Vigh A; Reglodi D
Curr Pharm Des; 2004; 10(23):2861-89. PubMed ID: 15379674
[TBL] [Abstract][Full Text] [Related]
5. PACAP as a neuroprotective factor in ischemic neuronal injuries.
Shioda S; Nakamachi T
Peptides; 2015 Oct; 72():202-7. PubMed ID: 26275482
[TBL] [Abstract][Full Text] [Related]
6. Distribution and functional characterization of pituitary adenylate cyclase-activating polypeptide receptors in the brain of non-human primates.
Jolivel V; Basille M; Aubert N; de Jouffrey S; Ancian P; Le Bigot JF; Noack P; Massonneau M; Fournier A; Vaudry H; Gonzalez BJ; Vaudry D
Neuroscience; 2009 May; 160(2):434-51. PubMed ID: 19236905
[TBL] [Abstract][Full Text] [Related]
7. Pituitary Adenylate Cyclase Activating Polypeptide Elicits Neuroprotection Against Acute Ischemic Neuronal Cell Death Associated with NMDA Receptors.
Kaneko Y; Tuazon JP; Ji X; Borlongan CV
Cell Physiol Biochem; 2018; 51(4):1982-1995. PubMed ID: 30513524
[TBL] [Abstract][Full Text] [Related]
8. Pituitary adenylate cyclase-activating polypeptide: focus on structure-activity relationships of a neuroprotective Peptide.
Bourgault S; Vaudry D; Dejda A; Doan ND; Vaudry H; Fournier A
Curr Med Chem; 2009; 16(33):4462-80. PubMed ID: 19835562
[TBL] [Abstract][Full Text] [Related]
9. Delayed pituitary adenylate cyclase-activating polypeptide delivery after brain stroke improves functional recovery by inducing m2 microglia/macrophage polarization.
Brifault C; Gras M; Liot D; May V; Vaudry D; Wurtz O
Stroke; 2015 Feb; 46(2):520-8. PubMed ID: 25550371
[TBL] [Abstract][Full Text] [Related]
10. Cloning and functional characterization of a third pituitary adenylate cyclase-activating polypeptide receptor subtype expressed in insulin-secreting cells.
Inagaki N; Yoshida H; Mizuta M; Mizuno N; Fujii Y; Gonoi T; Miyazaki J; Seino S
Proc Natl Acad Sci U S A; 1994 Mar; 91(7):2679-83. PubMed ID: 8146174
[TBL] [Abstract][Full Text] [Related]
11. Neurotrophic and neuroprotective effects of pituitary adenylate cyclase-activating polypeptide (PACAP) on mesencephalic dopaminergic neurons.
Takei N; Skoglösa Y; Lindholm D
J Neurosci Res; 1998 Dec; 54(5):698-706. PubMed ID: 9843161
[TBL] [Abstract][Full Text] [Related]
12. [Pituitary adenylate cyclase-activating polypeptide].
Gonzalez BJ; Basille M; Vaudry D; Fournier A; Vaudry H
Ann Endocrinol (Paris); 1998 Dec; 59(5):364-405. PubMed ID: 9949891
[TBL] [Abstract][Full Text] [Related]
13. The cyclic AMP effects and neuroprotective activities of PACAP and VIP in cultured astrocytes and neurons exposed to oxygen-glucose deprivation.
Jóźwiak-Bębenista M; Kowalczyk E; Nowak JZ
Pharmacol Rep; 2015 Apr; 67(2):332-8. PubMed ID: 25712659
[TBL] [Abstract][Full Text] [Related]
14. Protective effects of PACAP in ischemia.
Reglodi D; Vaczy A; Rubio-Beltran E; MaassenVanDenBrink A
J Headache Pain; 2018 Mar; 19(1):19. PubMed ID: 29500688
[TBL] [Abstract][Full Text] [Related]
15. Convergent phosphomodulation of the major neuronal dendritic potassium channel Kv4.2 by pituitary adenylate cyclase-activating polypeptide.
Gupte RP; Kadunganattil S; Shepherd AJ; Merrill R; Planer W; Bruchas MR; Strack S; Mohapatra DP
Neuropharmacology; 2016 Feb; 101():291-308. PubMed ID: 26456351
[TBL] [Abstract][Full Text] [Related]
16. Molecular, cellular, and functional characterizations of pituitary adenylate cyclase-activating polypeptide and its receptors in the cerebellum of New and Old World monkeys.
Aubert N; Basille M; Falluel-Morel A; Vaudry D; Bucharles C; Jolivel V; Fisch C; De Jouffrey S; Le Bigot JF; Fournier A; Vaudry H; Gonzalez BJ
J Comp Neurol; 2007 Oct; 504(4):427-39. PubMed ID: 17663433
[TBL] [Abstract][Full Text] [Related]
17. [Physiological significance of pituitary adenylate cyclase-activating polypeptide (PACAP) in the nervous system].
Hashimoto H
Yakugaku Zasshi; 2002 Dec; 122(12):1109-21. PubMed ID: 12510388
[TBL] [Abstract][Full Text] [Related]
18. Perspectives on pituitary adenylate cyclase activating polypeptide (PACAP) in the neuroendocrine, endocrine, and nervous systems.
Arimura A
Jpn J Physiol; 1998 Oct; 48(5):301-31. PubMed ID: 9852340
[TBL] [Abstract][Full Text] [Related]
19. Pituitary adenylate cyclase-activating polypeptide protects rat cerebellar granule neurons against ethanol-induced apoptotic cell death.
Vaudry D; Rousselle C; Basille M; Falluel-Morel A; Pamantung TF; Fontaine M; Fournier A; Vaudry H; Gonzalez BJ
Proc Natl Acad Sci U S A; 2002 Apr; 99(9):6398-403. PubMed ID: 11972030
[TBL] [Abstract][Full Text] [Related]
20. Pituitary adenylate cyclase activating polypeptide in the retina: focus on the retinoprotective effects.
Atlasz T; Szabadfi K; Kiss P; Racz B; Gallyas F; Tamas A; Gaal V; Marton Z; Gabriel R; Reglodi D
Ann N Y Acad Sci; 2010 Jul; 1200():128-39. PubMed ID: 20633141
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
